{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:12:32Z","timestamp":1758845552274},"reference-count":8,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T00:00:00Z","timestamp":1153785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2006,8]]},"abstract":"<jats:sec><jats:title>Summary<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>The current risk stratification systems in upper gastrointestinal bleeding do not correct for the intake of low\u2010dose aspirin and other antithrombotic drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To test the Blatchford scores in evaluating the clinical outcome in bleeders using these drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We calculated the Blatchford scores in 510 bleeders, including 123 on low\u2010dose aspirin, 44 on other antithrombotic drugs, and 68 on non\u2010steroidal anti\u2010inflammatory drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median clinical scores distributed according to aetiological risk factors were as follows: no risk factors, 5; non\u2010steroidal anti\u2010inflammatory drugs, 8; aspirin, 7; other antithrombotics, 6; excess alcohol, 4; multiple risk factors, 7; (<jats:italic>P<\/jats:italic>\u2003=\u20030.003, Kruskal\u2013Wallis test). Scores correlated positively with the duration of admission in the entire group (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>\u2003=\u20030.285; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) and in those taking aspirin and antithrombotics (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>\u2003=\u20030.211; <jats:italic>P<\/jats:italic>\u2003=\u20030.029). The median scores in patients requiring the blood transfusion were 10 in the entire group and 11 in users of aspirin or antithrombotics, compared with 3 and 4, respectively, in those not transfused (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The Blatchford scores are significantly elevated in users of non\u2010steroidal anti\u2010inflammatory drugs, low\u2010dose aspirin, and other antithrombotic drugs. They correlate positively with the duration of admission and the need for blood transfusion.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2006.03017.x","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T13:13:45Z","timestamp":1153833225000},"page":"633-636","source":"Crossref","is-referenced-by-count":17,"title":["Clinical outcome in upper gastrointestinal bleeding complicating low\u2010dose aspirin and antithrombotic drugs"],"prefix":"10.1111","volume":"24","author":[{"given":"A. S.","family":"TAHA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. J.","family":"ANGERSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. P.","family":"KNILL\u2010JONES","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"BLATCHFORD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02560.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1013010"},{"key":"e_1_2_6_4_2","first-page":"1842","article-title":"A scoring system to predict rebleeding after endoscopic therapy of nonvariceal upper gastrointestinal haemorrhage, with comparison of heat probe and ethanol injection","volume":"88","author":"Saeed ZA","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90607-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02816-6"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.50565.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02784.x"},{"key":"e_1_2_6_9_2","volume-title":"Antithrombotic Therapy, A National Clinical Guideline","author":"Scottish Intercollegiate Guideline Network, SIGN","year":"1999"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2006.03017.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2006.03017.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:04:04Z","timestamp":1697425444000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2006.03017.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,25]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["10.1111\/j.1365-2036.2006.03017.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03017.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,25]]}}}